江苏普罗赛生物技术有限公司成立于2010年，位于常州科教城开发园区，是一家由一批在生物技术领域有着多年成功经验的企业家和在海外生物医学界多年工作经验的资深技术专家共同投资成立的，集研发、生产和销售于一体的高科技生物技术公司。公司致力于开发独特的拥有自主专利知识产权的生物蛋白、细胞融合工程和技术，用来生产具有巨大科研和临床应用价值的蛋白质、酶和抗体。公司同时为生物药物公司或研发机构提供优质、快速和便捷的技术服务，包括基因表达载体的构建、基因突变、原核及真核体系中蛋白质或抗体的融合表达，以及稳定高量蛋白表达的单细胞株。

AbZyme Biotechnology lnc., founded in 2010, and located at the Science & Education Park, Changzhou, Jiangsu Province, is managed by experienced entrepreneurs in biotechnology and experts with many years of biomedical R&D. The company is committed to developing novel research technologies to manufacture biological substances including recombinant protein, enzyme and antibodies for applications in biomedical research and clinical diagnosis. The company is now establishing an innovative and dynamic R&D team and a state of the art biotechnology facility to develop biologics for the growing market needs in clinical diagnosis. The research team of the company provide contract research service to pharmaceutical and academic research organizations, specifically in gene cloning, plasmids construction and mutagenesis, protein expression in E. coli and mammalian cell systems, purification and characterization. The company supports customer to screen, isolate and identify high expression stable cell line for protein and antibody manufacturing.